Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
September 16, 2025 12:10 ET | Source: Quetzal Therapeutics CHICAGO, Sept. 16, 2025 (GLOBE NEWSWIRE) — Quetzal Therapeutics, a biopharmaceutical company focused on developing transformative therapies for patients with rare and life-threatening diseases, today announced the appointment of Dr. Shaad Abedin as Chief Medical Officer. Dr. Abedin brings to Quetzal extensive experience in oncology drug development, translational […]